We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Fluorescent Carbon Nanotubes Accurately Detect Bacteria and Viruses

By LabMedica International staff writers
Posted on 31 Jul 2023

An interdisciplinary research team that comprised scientists from Ruhr University Bochum (RUB, Bochum, Germany) has developed an innovative method to construct modular optical sensors capable of identifying viruses and bacteria. More...

The team utilized fluorescent carbon nanotubes attached to a novel type of DNA anchors which serve as molecular handles. These anchor structures can be utilized to conjugate biological recognition units such as antibodies aptamers to the nanotubes, enabling interaction with bacterial or viral molecules. This interaction impacts the fluorescence of the nanotubes, causing their brightness levels to increase or decrease.

The research team utilized tubular nanosensors composed of carbon, each with a diameter of less than one nanometer. When irradiated with visible light, these nanotubes emit near-infrared light, a spectrum invisible to the human eye but ideal for optical applications due to the significant reduction of other signals within this range. Previously, the team had successfully manipulated the nanotubes' fluorescence to detect vital biomolecules. Their latest effort involved customizing carbon sensors for easy detection of various target molecules.

This breakthrough was achieved with the help of DNA structures with guanine quantum defects. This process involved linking DNA bases to the nanotube in order to introduce a defect into the nanotube's crystal structure. Consequently, the nanotubes' fluorescence underwent a quantum-level change. In addition, the defect functioned as a molecular handle, enabling the addition of a detection unit that could be adjusted to the respective target molecule to identify a specific viral or bacterial protein.

The team demonstrated the new sensor concept by targeting the SARS-CoV-2 spike protein. Researchers used aptamers that bind to the SARS-CoV-2 spike protein, following which the fluorescent sensors reliably indicated the protein's presence. Notably, the selectivity and stability of sensors featuring guanine quantum defects surpassed those of sensors without such defects, especially when in solution.

Related Links:
Ruhr University Bochum


New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Plasma pTau217 testing can predict future amyloid accumulation and cognitive decline in cognitively healthy older adults (photo courtesy of Shutterstock)

Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms

Alzheimer's disease often advances silently for years, making timely risk stratification difficult in routine practice. Current approaches to detect pathology can involve lumbar puncture or positron emission... Read more

Industry

view channel
Image: The GenoPredict assay from Predicta Biosciences is available to Tempus Life Sciences partners to support exploratory research and clinical development programs (photo courtesy of Shutterstock)

Partnership Expands Ultrasensitive WGS Assay for for Hematologic Malignancies and MRD Monitoring

Tempus AI and Predicta Biosciences announced the commercial expansion of a co-branded whole‑genome sequencing assay GenoPredicta, which is intended for comprehensive genomic characterization of hematologic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.